The U.S. Supreme Court will hear the appeal of a decision awarding $21 million to a woman who suffered severe burns and was rendered permanently blind by the anti-inflammatory drug sulindac after a doctor prescribed it to treat her shoulder pain in 2004, according to the New York Times.

The U.S. Supreme Court has held that the Securities and Exchange Commission and other federal agencies must file cases pursuing civil penalties for fraudulent activity within five years of the day the fraud takes place, not within five years of the day the fraud is discovered.

The U.S. Supreme Court recently heard arguments in a case challenging the formula that is applied to determine which states are subject to “preclearance,” according to the New York Times.